Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)

Funding Opportunity RFA-AI-20-028 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of lead candidate therapeutics, vaccines and related countermeasures against select NIAID Emerging Infectious Diseases/Pathogens. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding